The store will not work correctly when cookies are disabled.
4-[(5-Oxo-1-phenylpyrrolidin-3-yl)amino]-benzenecarbohydroxamicAcid
ID: ALA3415450
Chembl Id: CHEMBL3415450
PubChem CID: 57524661
Max Phase: Preclinical
Molecular Formula: C17H17N3O3
Molecular Weight: 311.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NO)c1ccc(NC2CC(=O)N(c3ccccc3)C2)cc1
Standard InChI: InChI=1S/C17H17N3O3/c21-16-10-14(11-20(16)15-4-2-1-3-5-15)18-13-8-6-12(7-9-13)17(22)19-23/h1-9,14,18,23H,10-11H2,(H,19,22)
Standard InChI Key: OOLHXGYPFJFYFT-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 311.34 | Molecular Weight (Monoisotopic): 311.1270 | AlogP: 2.02 | #Rotatable Bonds: 4 |
Polar Surface Area: 81.67 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.24 | CX Basic pKa: 2.93 | CX LogP: 1.20 | CX LogD: 1.19 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.60 | Np Likeness Score: -1.33 |
References
1. Lin X, Chen W, Qiu Z, Guo L, Zhu W, Li W, Wang Z, Zhang W, Zhang Z, Rong Y, Zhang M, Yu L, Zhong S, Zhao R, Wu X, Wong JC, Tang G.. (2015) Design and synthesis of orally bioavailable aminopyrrolidinone histone deacetylase 6 inhibitors., 58 (6): [PMID:25734520] [10.1021/jm502011f] |